$MTEX
Mannatech Inc Stock $mtex

$mtex Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000105635820000092 Filed on November 10, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q4
Revenue	$39.20M	$38.00M	$39.40M
YoY Change	-0.51%	-4.28%	-10.45%
Cost Of Revenue	$10.50M	$9.328M	$8.300M
YoY Change	26.51%	20.97%	-8.79%
Gross Profit	$28.70M	$28.64M	$31.10M
YoY Change	-7.72%	-10.35%	-11.14%
Gross Profit Margin	73.21%	75.36%	78.93%
Selling, General & Admin	$23.20M	$21.70M	$22.50M
YoY Change	3.11%	-17.18%	-18.48%
% of Gross Profit	80.84%	75.77%	72.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$460.0K	$468.0K	$530.0K
YoY Change	-13.21%	-9.83%	-1.85%
% of Gross Profit	1.6%	1.63%	1.7%
Operating Expenses	$28.70M	$27.26M	$28.40M
YoY Change	1.06%	-13.14%	-19.77%
Operating Profit	$0.00	$1.380M	$2.700M
YoY Change	-100.0%	144.25%	-775.0%
Interest Expense	$0.00	$0.00	$100.0K
YoY Change	-100.0%		0.0%
% of Operating Profit		0.0%	3.7%
Other Income/Expense, Net	$900.0K	$248.0K	-$1.200M
YoY Change	-175.0%	-157.67%	200.0%
Pretax Income	$900.0K	$1.638M	$1.600M
YoY Change	-43.75%	1231.71%	-300.0%
Income Tax	$200.0K	$22.00K	-$500.0K
% Of Pretax Income	22.22%	1.34%	-31.25%
Net Earnings	$700.0K	$1.616M	$2.100M
YoY Change	-66.67%	-208.46%	-231.25%
Net Earnings / Revenue	1.79%	4.25%	5.33%
Basic Earnings Per Share		$0.77
Diluted Earnings Per Share	$333.3K	$0.76	$875.0K
COMMON SHARES
Basic Shares Outstanding	2.088M shares	2.100M shares	2.386M shares
Diluted Shares Outstanding		2.130M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.20M	$21.20M	$24.80M
YoY Change	-10.48%	-17.83%	13.76%
Cash & Equivalents	$22.21M	$21.23M	$24.76M
Short-Term Investments
Other Short-Term Assets	$12.00M	$11.70M	$9.600M
YoY Change	25.0%	105.26%	29.73%
Inventory	$12.80M	$13.50M	$10.20M
Prepaid Expenses
Receivables	$186.0K	$100.0K	$955.0K
Other Receivables	$1.000M	$900.0K	$200.0K
Total Short-Term Assets	$42.48M	$40.90M	$41.03M
YoY Change	3.53%	-6.94%	-3.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.400M	$12.40M	$6.100M
YoY Change	-11.48%	-3.13%	-9.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$12.00M	$11.71M	$9.600M
YoY Change	25.0%	12.26%	146.15%
Total Long-Term Assets	$22.86M	$22.14M	$21.89M
YoY Change	4.39%	-3.1%	10.51%
TOTAL ASSETS
Total Short-Term Assets	$42.48M	$40.90M	$41.03M
Total Long-Term Assets	$22.86M	$22.14M	$21.89M
Total Assets	$65.33M	$63.05M	$62.92M
YoY Change	3.83%	-5.63%	1.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.797M	$4.763M	$3.526M
YoY Change	36.05%	1.88%	-47.56%
Accrued Expenses	$8.691M	$7.800M	$8.209M
YoY Change	5.87%	-23.48%	36.93%
Deferred Revenue	$5.500M	$5.000M	$4.400M
YoY Change	25.0%	-12.31%	-16.57%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$600.0K	$800.0K	$800.0K
YoY Change	-25.0%	0.0%	0.0%
Total Short-Term Liabilities	$31.99M	$29.27M	$28.89M
YoY Change	10.71%	-15.93%	-14.05%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$200.0K	$500.0K
YoY Change	-80.0%	-71.43%	-50.0%
Other Long-Term Liabilities	$7.200M	$7.400M	$6.200M
YoY Change	16.13%	11.38%	169.57%
Total Long-Term Liabilities	$7.200M	$7.400M	$6.200M
YoY Change	16.13%	11.38%	169.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.99M	$29.27M	$28.89M
Total Long-Term Liabilities	$7.200M	$7.400M	$6.200M
Total Liabilities	$39.36M	$36.80M	$35.65M
YoY Change	10.42%	-12.71%	-3.32%
SHAREHOLDERS EQUITY
Retained Earnings	$2.213M	$3.908M	-$690.0K
YoY Change	-420.72%	-256.38%	-75.2%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$15.19M	$14.78M	$9.935M
YoY Change	52.85%	49.87%	-2.31%
Treasury Stock Shares	671.8K shares	653.9K shares	361.7K shares
Shareholders Equity	$25.97M	$26.24M	$27.28M
YoY Change
Total Liabilities & Shareholders Equity	$65.33M	$63.05M	$62.92M
YoY Change	3.83%	-5.63%	1.17%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q4
OPERATING ACTIVITIES
Net Income	$700.0K	$1.616M	$2.100M
YoY Change	-66.67%	-208.46%	-231.25%
Depreciation, Depletion And Amortization	$460.0K	$468.0K	$530.0K
YoY Change	-13.21%	-9.83%	-1.85%
Cash From Operating Activities	$2.750M	$800.0K	-$1.230M
YoY Change	-323.58%	-65.81%	-35.26%
INVESTING ACTIVITIES
Capital Expenditures	-$180.0K	-$290.0K	-$220.0K
YoY Change	-18.18%	-9.37%	-50.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00		$0.00
YoY Change
Cash From Investing Activities	-$180.0K	-$290.0K	-$220.0K
YoY Change	-18.18%	-9.37%	-51.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.060M	-820.0K	-620.0K
YoY Change	393.55%	9.33%	-61.96%
NET CHANGE
Cash From Operating Activities	2.750M	800.0K	-1.230M
Cash From Investing Activities	-180.0K	-290.0K	-220.0K
Cash From Financing Activities	-3.060M	-820.0K	-620.0K
Net Change In Cash	-490.0K	-310.0K	-2.070M
YoY Change	-76.33%	-124.41%	-47.99%
FREE CASH FLOW
Cash From Operating Activities	$2.750M	$800.0K	-$1.230M
Capital Expenditures	-$180.0K	-$290.0K	-$220.0K
Free Cash Flow	$2.930M	$1.090M	-$1.010M
YoY Change	-390.1%	-59.02%	-30.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Registrant Name EntityRegistrantName	MANNATECH INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001056358
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2087791	shares
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	787000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	708000	USD
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	99000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	99000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2742857	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2742857	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2089002	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2381131	shares
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	653855	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	361726	shares
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	700000	USD
CY2019Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	200000	USD
CY2019Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	200000	USD
CY2019Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	200000	USD
CY2019Q4	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	300000	USD
CY2019Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	300000	USD
CY2020Q4	us-gaap	Other Borrowings OtherBorrowings	2243687	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21234000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24762000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	943000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	943000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	144000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	955000	USD
CY2020Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	825000	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	220000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	13512000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	10152000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2516000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2239000	USD
CY2020Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1729000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1758000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	40903000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	41029000	USD
CY2020Q3	mtex	Property Plant And Equipment Net Excluding Construction In Progress PropertyPlantAndEquipmentNetExcludingConstructionInProgress	4007000	USD
CY2019Q4	mtex	Property Plant And Equipment Net Excluding Construction In Progress PropertyPlantAndEquipmentNetExcludingConstructionInProgress	5261000	USD
CY2020Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1411000	USD
CY2019Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	865000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4049000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5295000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11712000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9592000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	963000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	881000	USD
CY2020Q3	us-gaap	Assets Assets	63045000	USD
CY2019Q4	us-gaap	Assets Assets	62923000	USD
CY2020Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	77000	USD
CY2019Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	87000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4763000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3526000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7823000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8209000	USD
CY2020Q3	mtex	Commissions And Incentives Payable CommissionsAndIncentivesPayable	9807000	USD
CY2019Q4	mtex	Commissions And Incentives Payable CommissionsAndIncentivesPayable	9728000	USD
CY2020Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1080000	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2187000	USD
CY2020Q3	us-gaap	Notes Payable Current NotesPayableCurrent	689000	USD
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	739000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5034000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4416000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	29273000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28892000	USD
CY2020Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	152000	USD
CY2019Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	176000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3000	USD
CY2020Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2019Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	363000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7373000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6214000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	36801000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	35648000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33765000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34143000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3908000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-690000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3350000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3757000	USD
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	14779000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	9935000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	26244000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	27275000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63045000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	62923000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37966000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39656000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112218000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112218000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	118340000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	9328000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	7711000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	25044000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	25044000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	23253000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	28638000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	31945000	USD
	us-gaap	Gross Profit GrossProfit	87174000	USD
	us-gaap	Gross Profit GrossProfit	87174000	USD
	us-gaap	Gross Profit GrossProfit	95087000	USD
CY2020Q3	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	15089000	USD
CY2019Q3	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	16696000	USD
	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	45308000	USD
	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	45308000	USD
	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	48190000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6639000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8951000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20659000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20659000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24908000	USD
CY2020Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	468000	USD
CY2019Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	519000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1525000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1564000	USD
CY2020Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	5062000	USD
CY2019Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	5214000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	15180000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	15180000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	16721000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	27258000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	31380000	USD
	us-gaap	Operating Expenses OperatingExpenses	82672000	USD
	us-gaap	Operating Expenses OperatingExpenses	82672000	USD
	us-gaap	Operating Expenses OperatingExpenses	91383000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1380000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	565000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	4502000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	4502000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3704000	USD
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10000	USD
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	73000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	73000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-83000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	248000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-430000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	206000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	206000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	554000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1638000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	123000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4781000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4781000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4175000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1613000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-753000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-753000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2991000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	1616000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1490000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5534000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5534000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1184000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.42
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.42
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.38
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.38
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2098000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2391000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2286000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2393000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2135000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2391000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2312000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2450000	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	1616000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1490000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5534000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1184000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	679000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-763000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-407000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1393000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2295000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2253000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5127000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-209000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	27275000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	2787000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	300000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	83000	USD
CY2020Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	210000	USD
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	86000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1634000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	28335000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1130000	USD
CY2020Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	299000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2020Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5109000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	548000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	24639000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	1616000	USD
CY2020Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	336000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1000	USD
CY2020Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	355000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	679000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	26244000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	25324000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	688000	USD
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	303000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	107000	USD
CY2019Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	280000	USD
CY2019Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-441000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	25646000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1987000	USD
CY2019Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	300000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	160000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-1000	USD
CY2019Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	58000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-189000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	27245000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1490000	USD
CY2019Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	299000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	106000	USD
CY2019Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	0	USD
CY2019Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	154000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-763000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	24645000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5534000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1184000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1525000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1564000	USD
	mtex	Operating Right Of Use Lease Liabilities Net OperatingRightOfUseLeaseLiabilitiesNet	1746000	USD
	mtex	Operating Right Of Use Lease Liabilities Net OperatingRightOfUseLeaseLiabilitiesNet	1219000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	418000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	857000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	116000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-32000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-62000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	328000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	653000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-82000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	999000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-695000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	605000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-172000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3778000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	199000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	359000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1976000	USD
	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	-29000	USD
	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	-93000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1097000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-850000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1237000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2049000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2015000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-177000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1107000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	444000	USD
	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	79000	USD
	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	-1854000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	618000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	428000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3281000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6152000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	759000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	998000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	-8000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-767000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-998000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5550000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	221000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	936000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	902000	USD
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2244000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	-2244000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	373000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	968000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6859000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2091000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-429000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1346000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4774000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1717000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30584000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26226000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32301000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	969000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24762000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21845000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1089000	USD
	us-gaap	Interest Paid Net InterestPaidNet	56000	USD
	us-gaap	Interest Paid Net InterestPaidNet	93000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	25000	USD
	mtex	Non Cash Operating Lease Right Of Use Assets And Lease Liabilities NonCashOperatingLeaseRightOfUseAssetsAndLeaseLiabilities	0	USD
	mtex	Non Cash Operating Lease Right Of Use Assets And Lease Liabilities NonCashOperatingLeaseRightOfUseAssetsAndLeaseLiabilities	4730000	USD
	mtex	Non Cash Finance Lease Right Of Use Assets And Lease Liabilities NonCashFinanceLeaseRightOfUseAssetsAndLeaseLiabilities	0	USD
	mtex	Non Cash Finance Lease Right Of Use Assets And Lease Liabilities NonCashFinanceLeaseRightOfUseAssetsAndLeaseLiabilities	76000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2769000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2916000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	47000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	236000	USD
	mtex	Number Of Regions In Which Company Sells Products NumberOfRegionsInWhichCompanySellsProducts	3	region
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31000000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the consolidated financial statements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>
CY2020Q3	us-gaap	Credit Card Receivables CreditCardReceivables	2500000	USD
CY2019Q4	us-gaap	Credit Card Receivables CreditCardReceivables	700000	USD
CY2020Q3	us-gaap	Due From Banks DueFromBanks	15900000	USD
CY2019Q4	us-gaap	Due From Banks DueFromBanks	18200000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5000000.0	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6200000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	943000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1514000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5295000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7225000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30584000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21234000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24762000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	943000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	943000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4049000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5295000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26226000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31000000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	100000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1000000.0	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	800000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	700000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	11700000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9600000	USD
CY2020Q3	us-gaap	Security Deposit SecurityDeposit	2100000	USD
CY2019Q4	us-gaap	Security Deposit SecurityDeposit	2200000	USD
CY2020Q3	us-gaap	Deposit Assets DepositAssets	2400000	USD
CY2019Q4	us-gaap	Deposit Assets DepositAssets	1600000	USD
CY2019Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	200000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7800000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8200000	USD
CY2020Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	2100000	USD
CY2019Q4	mtex	Noninventoryaccrualcurrent Noninventoryaccrualcurrent	2200000	USD
CY2019Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	2300000	USD
CY2020Q3	mtex	Noninventoryaccrualcurrent Noninventoryaccrualcurrent	2000000.0	USD
CY2020Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1000000.0	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	900000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	800000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1200000	USD
CY2020Q3	us-gaap	Notes Payable NotesPayable	700000	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	1100000	USD
CY2020Q3	us-gaap	Notes Payable Current NotesPayableCurrent	700000	USD
CY2020Q3	us-gaap	Other Borrowings OtherBorrowings	2200000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7400000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6200000	USD
CY2020Q3	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	200000	USD
CY2020Q3	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	300000	USD
CY2020Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	300000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1800000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1000000.0	USD
CY2020Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1700000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4400000	USD
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2600000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5000000.0	USD
CY2020Q3	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3200000	USD
CY2019Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3100000	USD
CY2018Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	4231000	USD
CY2020Q1	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	4348000	USD
CY2020Q1	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	9127000	USD
CY2020Q1	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	11320000	USD
CY2020Q1	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	1051000	USD
CY2019Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3127000	USD
CY2019Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3127000	USD
	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	2601000	USD
	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	6879000	USD
	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	8404000	USD
	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	1145000	USD
CY2020Q3	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3196000	USD
	mtex	Percentage Of Sale Returns PercentageOfSaleReturns	0.015
CY2020Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	2716000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2685000	USD
CY2020Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11320000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8341000	USD
CY2020Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	524000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	874000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	13512000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	10152000	USD
CY2020Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.013
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.158
CY2019Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	13.114
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.716
	mtex	U.S.Net Operating Loss Carryback U.S.NetOperatingLossCarryback	1200000	USD
CY2020Q3	mtex	Average Share Price AverageSharePrice	17.00
	mtex	Average Share Price AverageSharePrice	14.76
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2290000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	30000.00	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2130000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2310000	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
CY2019Q3	mtex	Average Share Price AverageSharePrice	16.16
	mtex	Average Share Price AverageSharePrice	17.50
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2390000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	60000.00	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2450000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	370000	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	174393	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	15000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4.00
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	6.88
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	5000000.0	USD
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	5000000.0	USD
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	294117	shares
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	17.00
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	5000000.0	USD
CY2020Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	12238	shares
CY2020Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	17.06
CY2019Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	9560	shares
CY2019Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	16.07
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	323660	shares
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	294117	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	16.92
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	14097	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	16.38
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2089002	shares
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.125
CY2020Q1	us-gaap	Dividends Dividends	300000	USD
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.125
CY2020Q2	us-gaap	Dividends Dividends	300000	USD
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.16
CY2020Q3	us-gaap	Dividends Dividends	300000	USD
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	LITIGATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Administrative Proceeding</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Mannatech Korea, Ltd. v. Busan Custom Office</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, Busan District Court, Korea</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or before April 12, 2015, Mannatech Korea, Ltd. filed a suit against the Busan Custom Office (“BCO”) to challenge BCO’s method of calculation regarding its assessment notice issued on July 11, 2013. The assessment notice included </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an audit of the Company’s imported goods covering fiscal years 2008 through 2012 and required the Company to pay $1.0 million for this assessment, all of which was paid in January 2014. Both parties submitted a response to the Court’s inquiry on January 15, 2016. The final hearing for the case was held on May 26, 2016 where each party presented their respective arguments. The Court set the decision hearing on October 27, 2016, and the Court decided the case in the Company’s favor. However, on November 18, 2016, BCO filed an appeal to the Busan High Court. The first hearing occurred on March 31, 2017, and the second hearing occurred on April 21, 2017. The final hearing was held on June 2, 2017. The Court issued its decision on June 30, 2017 in favor of the BCO. The Company appealed this decision on August 24, 2017. On November 6, 2020, the Company received notice from counsel that the panel of justices assigned to this case conducted discussions on October 30, 2020. This is an indication, although not conclusive, that the Supreme Court may issue a decision by the end of the year or in the first quarter of 2021. This matter remains open.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Litigation - Product Liability</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Meeja Kim, et al., v. Mannatech Korea and Eunbee Cho, Seoul Southern District Court 2020-Gadan-216374</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 4, 2020, a complaint was filed against Mannatech Korea. Mannatech Korea was served on March 10, 2020. The plaintiffs are the surviving spouse and three children (the “Plaintiffs”) of Kong Seokhwan, a cancer patient who died in October 2017. The Plaintiffs allege that co-defendant and former independent associate, Eunbee Cho, instructed the deceased to take the Company’s products as treatment for cancer. Eunbee Cho was found guilty of fraud and began serving a sentence of one year and six months in November 2019. The Plaintiffs are seeking damages in the amount of 110 million KRW (USD $90,000.00) plus interest of 12% per year. Mannatech Korea has engaged local counsel to defend this matter. An evidentiary hearing was held on October 21, 2020. The next hearing is scheduled for December 9, 2020. It is not possible at this time to predict whether the Company will incur any liability, or to estimate the ranges of damages, if any, which may be incurred in connection with this matter. However, Mannatech Korea believes it has a valid defense and will vigorously defend this claim. This matter remains open.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Ruiguo Ma v. MTEX Hong Kong Limited and Beili Guan, Case No. 2019-Jin-0116-Civil-2339, Binhai New District Court, Tianjin, China</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or before September 2, 2019, MTEX Hong Kong received service of process of the above-captioned matter. Ruiguo Ma, (the "Plaintiff") is alleging that his child suffered tooth decay after consuming the Company's MannaBears product and underwent several surgeries. The Plaintiff is seeking damages of approximately $50,000 USD. The Company has engaged local counsel to defend this case. The Company has provided notice to its insurance carrier. At this time the potential damages do not meet the deductible; therefore, the case has not been tendered to the carrier. The first hearing occurred on September 11, 2019, and the second hearing occurred on October 30, 2019, where each party presented their respective arguments. On August 25, 2020, the court denied all of the Plaintiff's motions and granted judgment in favor of the MTEX Hong Kong. The Plaintiff appealed the decision on September 21, 2020. MTEX Hong Kong has engaged the same counsel to defend against the appeal. This matter remains open.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Litigation in General</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on our consolidated financial position, results of operations, or cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The outcome of litigation is uncertain, and despite management’s views of the merits of any litigation, or the reasonableness of the Company’s estimates and reserves, the Company’s financial statements could nonetheless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from current legal matters where an outcome was deemed to be probable, and the loss amount could be reasonably estimated.</span></div>
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	8300000	USD
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	200000	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M21D
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2020Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y11M1D
CY2020Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.056
CY2020Q3	mtex	Financeand Operating Lease Assets FinanceandOperatingLeaseAssets	7269000	USD
CY2019Q3	mtex	Financeand Operating Lease Assets FinanceandOperatingLeaseAssets	6793000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112200000	USD
CY2020Q3	mtex	Financeand Operating Lease Liabilities FinanceandOperatingLeaseLiabilities	8535000	USD
CY2019Q3	mtex	Financeand Operating Lease Liabilities FinanceandOperatingLeaseLiabilities	7988000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	625000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	24000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2201000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	91000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1737000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	73000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1174000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	45000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1259000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	21000	USD
CY2020Q3	mtex	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	872000	USD
CY2020Q3	mtex	Finance Lease Liability Payments Due Year Six FinanceLeaseLiabilityPaymentsDueYearSix	1000	USD
CY2020Q3	mtex	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	1528000	USD
	mtex	Number Of Regions In Which Company Sells Products NumberOfRegionsInWhichCompanySellsProducts	3	region
CY2020Q3	mtex	Finance Lease Liability Payments Due After Year Six FinanceLeaseLiabilityPaymentsDueAfterYearSix	0	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9396000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	255000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1090000	USD
CY2020Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	26000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	8306000	USD
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	229000	USD
	mtex	Number Of Countries In Which Entity Network Marketing And Distribution Channels Operates NumberOfCountriesInWhichEntityNetworkMarketingAndDistributionChannelsOperates	24	country
CY2020Q3	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	11	country
	mtex	Number Of Countries In Which Entity Sells Products NumberOfCountriesInWhichEntitySellsProducts	25	country
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38000000.0	USD
CY2020Q3	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39700000	USD
CY2019Q3	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112200000	USD
	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	118300000	USD
	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38000000.0	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39700000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	118300000	USD
CY2020Q3	us-gaap	Noncurrent Assets NoncurrentAssets	5400000	USD
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	6100000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	13500000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	10200000	USD

Files In Submission

Name	View Source	Status
0001056358-20-000092-index-headers.html	Edgar Link	pending
0001056358-20-000092-index.html	Edgar Link	pending
0001056358-20-000092.txt	Edgar Link	pending
0001056358-20-000092-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mtex-20200930.htm	Edgar Link	pending
mtex-20200930.xsd	Edgar Link	pending
mtex-20200930_cal.xml	Edgar Link	unprocessable
mtex-20200930_def.xml	Edgar Link	unprocessable
mtex-20200930_htm.xml	Edgar Link	completed
mtex-20200930_lab.xml	Edgar Link	unprocessable
mtex-20200930_pre.xml	Edgar Link	unprocessable
mtexq3202010-qexh311.htm	Edgar Link	pending
mtexq3202010-qexh312.htm	Edgar Link	pending
mtexq3202010-qexh321.htm	Edgar Link	pending
mtexq3202010-qexh322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MTEX
Mannatech Inc Stock $mtex

2020 Q4 Form 10-Q Financial Statement

#000105635820000092 Filed on November 10, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MTEX Mannatech Inc Stock $mtex

2020 Q4 Form 10-Q Financial Statement

#000105635820000092 Filed on November 10, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MTEX
Mannatech Inc Stock $mtex